Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)

Samuel G. Awuah; Yao Rong Zheng; Peter M. Bruno; Michael T. Hemann; Stephen J. Lippard

doi:10.1021/jacs.6b01316

Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)

Samuel G. Awuah, Yao Rong Zheng, Peter M. Bruno, Michael T. Hemann, Stephen J. Lippard

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Original language	English
Pages (from-to)	3250
Number of pages	1
Journal	Journal of the American Chemical Society
Volume	138
Issue number	9
DOIs	https://doi.org/10.1021/jacs.6b01316
State	Published - Mar 9 2016

ASJC Scopus subject areas

Catalysis
General Chemistry
Biochemistry
Colloid and Surface Chemistry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/jacs.6b01316

Fingerprint

Dive into the research topics of 'Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)'. Together they form a unique fingerprint.

Cite this

Awuah, S. G., Zheng, Y. R., Bruno, P. M., Hemann, M. T., & Lippard, S. J. (2016). Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182). Journal of the American Chemical Society, 138(9), 3250. https://doi.org/10.1021/jacs.6b01316

Awuah, Samuel G. ; Zheng, Yao Rong ; Bruno, Peter M. et al. / Erratum : A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182). In: Journal of the American Chemical Society. 2016 ; Vol. 138, No. 9. pp. 3250.

@article{759cdd112ad143ed8cd4cf49663e5415,

title = "Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)",

author = "Awuah, {Samuel G.} and Zheng, {Yao Rong} and Bruno, {Peter M.} and Hemann, {Michael T.} and Lippard, {Stephen J.}",

year = "2016",

month = mar,

day = "9",

doi = "10.1021/jacs.6b01316",

language = "English",

volume = "138",

pages = "3250",

number = "9",

}

Awuah, SG, Zheng, YR, Bruno, PM, Hemann, MT & Lippard, SJ 2016, 'Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)', Journal of the American Chemical Society, vol. 138, no. 9, pp. 3250. https://doi.org/10.1021/jacs.6b01316

Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182). / Awuah, Samuel G.; Zheng, Yao Rong; Bruno, Peter M. et al.
In: Journal of the American Chemical Society, Vol. 138, No. 9, 09.03.2016, p. 3250.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)

AU - Awuah, Samuel G.

AU - Zheng, Yao Rong

AU - Bruno, Peter M.

AU - Hemann, Michael T.

AU - Lippard, Stephen J.

PY - 2016/3/9

Y1 - 2016/3/9

UR - http://www.scopus.com/inward/record.url?scp=84960415456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960415456&partnerID=8YFLogxK

U2 - 10.1021/jacs.6b01316

DO - 10.1021/jacs.6b01316

M3 - Comment/debate

AN - SCOPUS:84960415456

SN - 0002-7863

VL - 138

SP - 3250

JO - Journal of the American Chemical Society

JF - Journal of the American Chemical Society

IS - 9

ER -

Awuah SG, Zheng YR, Bruno PM, Hemann MT, Lippard SJ. Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182). Journal of the American Chemical Society. 2016 Mar 9;138(9):3250. doi: 10.1021/jacs.6b01316

Erratum: A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy (Journal of the American Chemical Society (2015) 137 (14854-14857) DOI: 10.1021/jacs.5b10182)

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this